Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

504 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Among authors: massy za. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.
Rossignol P, Duarte K, Bresso E, A Å, Devignes MD, Eriksson N, Girerd N, Glerup R, Jardine AG, Holdaas H, Lamiral Z, Leroy C, Massy Z, März W, Krämer B, Wu PH, Schmieder R, Soveri I, Christensen JH, Svensson M, Zannad F, Fellström B. Rossignol P, et al. Eur Heart J Open. 2022 Nov 9;2(6):oeac069. doi: 10.1093/ehjopen/oeac069. eCollection 2022 Nov. Eur Heart J Open. 2022. PMID: 36600882 Free PMC article.
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.
El Chamieh C, Larabi IA, Alencar De Pinho N, Lambert O, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Laville S, Lange C, Alvarez JC, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. El Chamieh C, et al. Among authors: massy za. Clin Kidney J. 2023 Sep 28;17(1):sfad248. doi: 10.1093/ckj/sfad248. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186868 Free PMC article.
International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?
Calice-Silva V, Muenz D, Wong MMY, McCullough K, Charytan D, Reichel H, Robinson B, Stengel B, Massy ZA, Pecoits-Filho R; CKDopps Investigators. Calice-Silva V, et al. Among authors: massy za. Lipids Health Dis. 2023 May 25;22(1):67. doi: 10.1186/s12944-023-01833-z. Lipids Health Dis. 2023. PMID: 37231413 Free PMC article.
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
Writing Group for the CKD Prognosis Consortium; Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT. Writing Group for the CKD Prognosis Consortium, et al. JAMA. 2023 Oct 3;330(13):1266-1277. doi: 10.1001/jama.2023.17002. JAMA. 2023. PMID: 37787795 Free PMC article.
Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events.
Le Gall L, Harambat J, Combe C, Philipps V, Proust-Lima C, Dussartre M, Drüeke T, Choukroun G, Fouque D, Frimat L, Jacquelinet C, Laville M, Liabeuf S, Pecoits-Filho R, Massy ZA, Stengel B, Alencar de Pinho N, Leffondré K, Prezelin-Reydit M; CKD-REIN study group. Le Gall L, et al. Among authors: massy za. Nephrol Dial Transplant. 2024 Mar 27;39(4):669-682. doi: 10.1093/ndt/gfad235. Nephrol Dial Transplant. 2024. PMID: 37935529
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD.
Laville SM, Gras-Champel V, Hamroun A, Moragny J, Lambert O, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Bieber B, Stengel B, Alencar De Pinho N, Massy ZA, Liabeuf S; CKD-REIN Study Group. Laville SM, et al. Among authors: massy za. Am J Kidney Dis. 2024 May;83(5):601-614.e1. doi: 10.1053/j.ajkd.2023.09.012. Epub 2023 Nov 10. Am J Kidney Dis. 2024. PMID: 37951340 Free article.
[Chronic kidney disease and nephrological practices in France: lessons from the CKD-REIN cohort, 2013-2023].
Alencar de Pinho N, Metzger M, Hamroun A, Laville S, Prezelin-Reydit M, Combe C, Fouque D, Laville M, Massy Z, Herpe YÉ, Untas A, Jacquelinet C, Liabeuf S, Frimat L, Stengel B; le groupe d’étude Chronic Kidney Disease – Renal Epidemiology and Information Network (CKD-REIN). Alencar de Pinho N, et al. Nephrol Ther. 2023 Aug 3;19(4):233-250. doi: 10.1684/ndt.2023.35. Epub 2023 Jul 17. Nephrol Ther. 2023. PMID: 37533268 Review. French.
[Sclerostin: a new biomarker of interest in nephrology].
Pelletier S, Jean G, Fouque D; Groupe de Travail Mixte SFBC SN Biomarqueurs des Calcifications Vasculaires Au Cours de L'insuffisance Rénale Chronique. Pelletier S, et al. Ann Biol Clin (Paris). 2015 May-Jun;73(3):305-13. doi: 10.1684/abc.2015.1049. Ann Biol Clin (Paris). 2015. PMID: 26069067 Free article. French.
504 results